Mapping the scope of drug patents
Science · 29.10.2026 · 394 (6823) · 496-498
DOI: 10.1126/science.aeh0691 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 29.10.2026. Verfasst von Janet Freilich und 3 weiteren Autor:innen. Beteiligte Einrichtung: Boston University School of Law, Boston, MA, USA. Hauptthemen laut MEDLINE: Patents as Topic, Drug Industry. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Narrowing patents that claim more than they disclose would open space for rival innovators, not generics
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Boston University School of Law, Boston, MA, USA.
- IBM Research-Zurich, Rüschlikon, Switzerland.
- Stanford Law School, Stanford University, Stanford, CA, USA.
Zitieren
APA
Freilich, J., Dinkla, K., Meijer, G. I., & Ouellette, L. L. (2026). Mapping the scope of drug patents. Science, 394(6823), 496-498. https://doi.org/10.1126/science.aeh0691
Vancouver
Freilich J, Dinkla K, Meijer GI, Ouellette LL. Mapping the scope of drug patents. Science. 2026;394(6823):496-498. doi:10.1126/science.aeh0691
BibTeX
@article{Freilich2026,
author = {Freilich, Janet and Dinkla, Kasper and Meijer, Gerhard Ingmar and Ouellette, Lisa Larrimore},
title = {Mapping the scope of drug patents},
journal = {Science},
year = {2026},
volume = {394},
number = {6823},
pages = {496--498},
doi = {10.1126/science.aeh0691}
}
EUVIMED